A detailed history of Kistler Tiffany Companies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 12,863 shares of BMY stock, worth $749,012. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,863
Previous 12,315 4.45%
Holding current value
$749,012
Previous $853,000 3.63%
% of portfolio
0.13%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$63.71 - $70.74 $34,913 - $38,765
548 Added 4.45%
12,863 $822,000
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $1,117 - $1,267
17 Added 0.14%
12,315 $853,000
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $3,971 - $4,703
-58 Reduced 0.47%
12,298 $884,000
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $57 - $33,886
-441 Reduced 3.45%
12,356 $878,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $1,379 - $1,519
19 Added 0.15%
12,797 $985,000
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $46,601 - $55,879
-758 Reduced 5.6%
12,778 $933,000
Q4 2021

Jan 25, 2022

SELL
$53.63 - $62.52 $179,767 - $209,567
-3,352 Reduced 19.85%
13,536 $844,000
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $55,383 - $64,874
-936 Reduced 5.25%
16,888 $999,000
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $309 - $337
5 Added 0.03%
17,824 $1.19 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $76,785 - $86,361
1,294 Added 7.83%
17,819 $1.13 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $35,163 - $39,846
609 Added 3.83%
16,525 $1.03 Million
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $109,921 - $121,806
-1,914 Reduced 10.73%
15,916 $960,000
Q2 2020

Jul 20, 2020

BUY
$54.82 - $64.09 $179,151 - $209,446
3,268 Added 22.44%
17,830 $1.05 Million
Q4 2019

Jan 14, 2020

BUY
$49.21 - $64.19 $136,114 - $177,549
2,766 Added 23.45%
14,562 $935,000
Q3 2019

Oct 18, 2019

BUY
$42.77 - $50.71 $25,234 - $29,918
590 Added 5.27%
11,796 $598,000
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $37,703 - $41,692
-845 Reduced 7.01%
11,206 $508,000
Q1 2019

Apr 16, 2019

BUY
$45.12 - $53.8 $26,350 - $31,419
584 Added 5.09%
12,051 $575,000
Q4 2018

Jan 14, 2019

SELL
$48.76 - $63.23 $59,487 - $77,140
-1,220 Reduced 9.62%
11,467 $596,000
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $21,744 - $24,526
-394 Reduced 3.01%
12,687 $788,000
Q2 2018

Jul 17, 2018

SELL
$50.53 - $62.98 $82,313 - $102,594
-1,629 Reduced 11.07%
13,081 $724,000
Q1 2018

Apr 06, 2018

SELL
$59.92 - $68.98 $41,464 - $47,734
-692 Reduced 4.49%
14,710 $930,000
Q4 2017

Jan 11, 2018

BUY
$59.94 - $65.35 $10,309 - $11,240
172 Added 1.13%
15,402 $944,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $841,152 - $970,760
15,230
15,230 $971,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.